Immune checkpoint inhibitors in oncogene-addicted non-small cell lung cancer: a systematic review and meta-analysis

BACKGROUND: Treatment of oncogene-addicted non-small cell lung cancer (NSCLC) has been changed by the advent of tyrosine kinase inhibitors (TKIs). Albeit great benefits are achieved with target therapies, resistance invariably occurs and recourse to alternative treatments is unavoidable. Immune chec...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Transl Lung Cancer Res
Auteurs principaux: Guaitoli, Giorgia, Tiseo, Marcello, Di Maio, Massimo, Friboulet, Luc, Facchinetti, Francesco
Format: Artigo
Langue:Inglês
Publié: AME Publishing Company 2021
Sujets:
Original Article on Immunotherapy in Other Thoracic Malignancies and Uncommon Populations
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8264334/
https://ncbi.nlm.nih.gov/pubmed/34295687
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr-20-941
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires